# How to Diagnose Cancer Better Using Multiple Blood Markers and Patient Data

> This patent describes a method for improving cancer diagnosis by combining measurements of several biological markers with patient-specific information like age or body mass, transforming them into a special score, and then comparing that score to a model of known cancer cases.

- **Patent:** US 20230274838
- **Original title:** Method for improving disease diagnosis using measured analytes
- **Owner:** OTRACES
- **Status:** Active
- **Times cited:** 0
- **Field:** biotech, pharmaceutical, software, ai_ml, telecommunications

## What it does

This method aims to improve cancer diagnosis and treatment by analyzing a subject's biological samples. First, it receives concentrations of at least three specific biological markers, called analytes, from a patient's sample (Claim 1a). Then, it selects additional patient details, known as meta-variables, such as age, body mass, or menopausal status, which are known to vary in the general population (Claim 1b, Claim 2). These analyte concentrations are then transformed, using both population data and the selected meta-variables, into a special unitless number called a "pseudo-concentration" for each analyte (Claim 1c). These pseudo-concentrations are scored against a pre-built model of pseudo-concentrations from people known to have or not have the disease (Claim 1d). Finally, based on this score, the method diagnoses whether the subject has cancer, provided the diagnostic model performs with at least 75% accuracy in avoiding false positives and negatives, and then suggests administering anti-cancer drugs (Claim 1e). For example, a doctor could use this system to get a more accurate cancer diagnosis for a patient by inputting their blood test results and their age, and the system would output a diagnosis and treatment recommendation.

## What it does NOT cover

- Does not cover diagnostic methods that use fewer than three predetermined analytes.
- Does not cover diagnostic methods that do not incorporate meta-variables specific to the subject's population, like age or body mass.
- Does not cover diagnostic methods where the raw analyte concentrations are not transformed into unitless, clinically predictive pseudo-concentrations.
- Does not cover diagnostic models with a false negative and false positive performance worse than 75%.
- Does not cover diagnostic methods that only provide a diagnosis without also including the administration of anti-cancer drugs.

## The clever bit

The truly clever part is transforming raw analyte concentrations into "pseudo-concentrations" by factoring in patient-specific meta-variables and population distribution characteristics. This normalizes the data, making the diagnostic score more robust and less prone to variations caused by individual differences, thus improving diagnostic accuracy.

## Real-world examples

1. Personalized cancer diagnostic panels
2. AI-powered medical diagnostic systems
3. Advanced blood tests for early disease detection
4. Precision oncology treatment planning tools

## Why it matters

Accurate and early cancer diagnosis is critical for effective treatment. This patent matters because it proposes a way to make diagnostic tests more precise by accounting for individual patient characteristics and population differences, rather than relying solely on raw biomarker levels. By integrating meta-variables, it aims to reduce misdiagnoses, which can lead to better patient outcomes and more targeted treatment plans. This approach could help personalize medicine by making diagnostic results more relevant to each unique patient.

## Frequently asked questions

### What does How to Diagnose Cancer Better Using Multiple Blood Markers and Patient Data cover?

This patent describes a method for improving cancer diagnosis by combining measurements of several biological markers with patient-specific information like age or body mass, transforming them into a special score, and then comparing that score to a model of known cancer cases.

### Who owns patent US 20230274838?

This patent is owned by OTRACES.

### When does this patent expire?

This patent is expected to expire on May 5, 2043, when the invention enters the public domain.

### What problem does this patent solve?

Accurate and early cancer diagnosis is critical for effective treatment. This patent matters because it proposes a way to make diagnostic tests more precise by accounting for individual patient characteristics and population differences, rather than relying solely on raw biomarker levels. By integrating meta-variables, it aims to reduce misdiagnoses, which can lead to better patient outcomes and more targeted treatment plans. This approach could help personalize medicine by making diagnostic results more relevant to each unique patient.

### What does this patent NOT cover?

Does not cover diagnostic methods that use fewer than three predetermined analytes.

**Full plain-English explainer:** https://patentbrief.org/patent/us/20230274838/method-for-improving-disease-diagnosis-using-measured-analytes

**Original patent:** https://patents.google.com/patent/US20230274838

---

_Source: PatentBrief — https://patentbrief.org. Patent facts are from public records; the plain-English explanation is PatentBrief's._


## Related patents

Semantically similar inventions in the PatentBrief corpus:

- [Method for Diagnosing Ovarian Cancer Using Biomarkers](https://patentbrief.org/patent/us/8053198/diagnostic-methods) — This patent describes a method to diagnose ovarian cancer by measuring specific protein levels in a patient's blood sample and comparing them to normal levels.
- [Using Blood and Saliva mRNA to Detect Breast Cancer](https://patentbrief.org/patent/us/20240117444/biomarkers-for-the-diagnosis-of-breast-cancer) — This patent describes a method using specific messenger RNA (mRNA) levels in blood or saliva to help detect breast cancer or determine its prognosis.
- [Finding Rare Genetic Changes in Blood Using DNA Fragments](https://patentbrief.org/patent/us/12735751/systems-and-methods-to-detect-rare-mutations-and-copy-number-variation) — This patent describes a system and method for detecting uncommon genetic mutations and changes in gene copy numbers from DNA fragments found freely in bodily fluids, like blood.
- [AI Predicts Prostate Cancer Spread from Medical Scans](https://patentbrief.org/patent/us/12737884/systems-and-methods-for-ai-assisted-analysis-of-primary-tumor-images-for) — This patent describes how artificial intelligence can analyze medical scans of a prostate tumor to automatically identify suspect regions and predict if the cancer will spread to other parts of the body.
- [AI System for Analyzing Medical Images Using Magnification-Aligned Transformers](https://patentbrief.org/patent/us/20260080696/method-and-system-for-analyzing-pathological-images-based-on-magnification-align) — This 2025 patent describes an AI system that analyzes medical images, like those from pathology slides, by using a special 'Transformer' model that understands how image details change with magnification.
